{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:55:23Z","timestamp":1790258123866,"version":"4.1.0"},"publisher-location":"Cham","reference-count":10,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319754017","type":"print"},{"value":"9783319754024","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-3-319-75402-4_55","type":"book-chapter","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T13:23:42Z","timestamp":1525267422000},"page":"447-455","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Valproic Acid Inhibits Human Retinal Pigment Epithelial (hRPE) Cell Proliferation Via a P38 MAPK Signaling Mechanism"],"prefix":"10.1007","author":[{"given":"Rohit","family":"Anand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyush C.","family":"Kothary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monte A.","family":"Del Monte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,3]]},"reference":[{"key":"55_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-3-319-17121-0_6","volume":"854","author":"AK Berner","year":"2016","unstructured":"Berner AK, Kleinman ME (2016) Therapeutic approaches to histone reprogramming in retinal degeneration. Adv Exp Med Biol 854:39\u201344","journal-title":"Adv Exp Med Biol"},{"key":"55_CR2","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/eye.2001.141","volume":"15","author":"M Boulton","year":"2001","unstructured":"Boulton M, Dayhaw-Barker P (2001) The role of the retinal pigment epithelium: topographical variation and ageing changes. Eye (Lond) 15:384\u2013389","journal-title":"Eye (Lond)"},{"key":"55_CR3","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.2147\/OPTH.S109995","volume":"10","author":"S Iraha","year":"2016","unstructured":"Iraha S, Hirami Y, Ota S, Sunagawa GA, Mandai M, Tanihara H, Takahashi M, Kurimoto Y (2016) Efficacy of valproic acid for retinitis pigmentosa patients: a pilot study. Clin Ophthalmol 10:1375\u20131384","journal-title":"Clin Ophthalmol"},{"key":"55_CR5","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/978-3-319-17121-0_102","volume":"854","author":"PC Kothary","year":"2016","unstructured":"Kothary PC, Rossi B, Del Monte MA (2016) Valproic acid induced human retinal pigment epithelial cell death as well as its survival after hydrogen peroxide damage is mediated by P38 Kinase. Adv Exp Med Biol 854:765\u2013772","journal-title":"Adv Exp Med Biol"},{"key":"55_CR6","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1089\/jop.2013.0166","volume":"30","author":"A Kumar","year":"2014","unstructured":"Kumar A, Midha N, Gogia V, Gupta S, Sehra S, Chohan A (2014) Efficacy of oral valproic acid in patients with retinitis pigmentosa. J Ocul Pharmacol Ther 30:580\u2013586","journal-title":"J Ocul Pharmacol Ther"},{"key":"55_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2174\/1874467210902010095","volume":"2","author":"B Monti","year":"2009","unstructured":"Monti B, Polazzi E, Contestabile A (2009) Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection. Curr Mol Pharmacol 2:95\u2013109","journal-title":"Curr Mol Pharmacol"},{"key":"55_CR9","first-page":"1325","volume":"6","author":"A Sadaka","year":"2012","unstructured":"Sadaka A, Giuliari GP (2012) Proliferative vitreoretinopathy: current and emerging treatments. Clin Ophthalmol 6:1325\u20131333","journal-title":"Clin Ophthalmol"},{"key":"55_CR10","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1177\/1535370215587530","volume":"240","author":"J Stern","year":"2015","unstructured":"Stern J, Temple S (2015) Retinal pigment epithelial cell proliferation. Exp Biol Med (Maywood) 240:1079\u20131086","journal-title":"Exp Biol Med (Maywood)"},{"key":"55_CR11","doi-asserted-by":"publisher","first-page":"867","DOI":"10.3109\/02713680903177890","volume":"34","author":"CY Weng","year":"2009","unstructured":"Weng CY, Kothary PC, Verkade AJ, Reed DM, Del Monte MA (2009) MAP kinase pathway is involved in IGF-1-stimulated proliferation of human retinal pigment epithelial cells (hRPE). Curr Eye Res 34:867\u2013876","journal-title":"Curr Eye Res"},{"key":"55_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.neulet.2010.07.004","volume":"482","author":"N Xie","year":"2010","unstructured":"Xie N, Wang C, Lin Y, Li H, Chen L, Zhang T, Sun Y, Zhang Y, Yin D, Chi Z (2010) The role of p38 MAPK in valproic acid induced microglia apoptosis. Neurosci Lett 482:51\u201356","journal-title":"Neurosci Lett"}],"container-title":["Advances in Experimental Medicine and Biology","Retinal Degenerative Diseases"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-75402-4_55","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T13:30:54Z","timestamp":1525267854000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-75402-4_55"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9783319754017","9783319754024"],"references-count":10,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-75402-4_55","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}